Numerous studies have highlighted the significance of artificial intelligence (AI) in breast cancer diagnosis. However, systematic reviews of AI applications in this field often lack cohesion, with each study adopting a unique approach. The aim of this study is to provide a detailed examination of AI's role in breast cancer diagnosis through citation analysis, helping to categorize the key areas that attract academic attention. It also includes a thematic analysis to identify the specific research topics within each category. A total of 30,200 studies related to breast cancer and AI, published between 2015 and 2024, were sourced from databases such as IEEE, Scopus, PubMed, Springer, and Google Scholar. After applying inclusion and exclusion criteria, 32 relevant studies were identified. Most of these studies utilized classification models for breast cancer prediction, with high accuracy being the most commonly reported performance metric. Convolutional Neural Networks (CNN) emerged as the preferred model in many studies. The findings indicate that both the quantity and quality of AI-based algorithms in breast cancer diagnosis are increases in the given years. AI is increasingly seen as a complement to healthcare sector and clinical expertise, with the target of enhancing the accessibility and affordability of quality healthcare worldwide.

Detection and management of diabetes at an early stage is essential since it is rapidly becoming a global health crisis in many countries. Predictions of diabetes using machine learning algorithms have been promising. In this work, we use data collected from the Pima Indians to assess the performance of multiple machine-learning approaches to diabetes prediction. Ages, body mass indexes, and glucose levels for 768 patients are included in the data set. The methods evaluated are Logistic Regression, Decision Tree, Random Forest, k-Nearest Neighbors, Naive Bayes, Support Vector Machine, Gradient Boosting, and Neural Network. The findings indicate that the Logistic Regression and Neural Network models perform the best on most criteria when considering all classes together. The SVM, Random Forest, and Naive Bayes models also receive moderate to high scores, suggesting their strength as classification models. However, the kNN and Tree models show poorer scores on most criteria across all classes, making them less favorable choices for this dataset. The SGD, AdaBoost, and CN2 rule inducer models perform the poorest when comparing all models using a weighted average of class scores. The results of the study suggest that machine learning algorithms may help predict the onset of diabetes and for detecting the disease at an early stage.

In this study, we evaluated the performance of various machine-learning models on multiple datasets labeled GR1, GR2, GR3, GR4, and GR5. We assessed the models using a range of evaluation metrics, including AUC, CA, F1, precision, recall, MCC, specificity, and log loss. The models examined were logistic regression, decision tree, kNN, random forest, gradient boosting, neural network, AdaBoost, and stochastic gradient descent. The results indicate that all models consistently demonstrated outstanding performance across all datasets, with most achieving perfect scores in all metrics. The models exhibited high accuracy and effectiveness in accurately classifying instances. Although random forests displayed slightly lower scores in some metrics, theyi still maintained an overall high level of accuracy. The findings highlight the models’ ability to effectively learn the underlying patterns within the data and make accurate predictions. The low log loss values further confirmed the models’ precise estimation of probabilities. Consequently, these models possess strong potential for practical applications in various domains, offering reliable and robust classification capabilities.

Artificial intelligence (AI) holds significant potential to revolutionize healthcare by improving clinical practices and patient outcomes. This research explores the integration of AI in healthcare, focusing on methodologies such as machine learning, natural language processing, and computer vision, which enable the extraction of valuable insights from complex medical imaging and clinical data. Through a comprehensive literature review, the study highlights AI’s practical applications in diagnostics, treatment planning, and predicting patient outcomes. Additionally, ethical issues, data privacy, and legal frameworks are examined, emphasizing the importance of responsible AI usage in healthcare. The findings demonstrate AI’s ability to enhance diagnostic accuracy, streamline administrative tasks, and optimize resource allocation, leading to personalized treatments and more efficient healthcare management. However, challenges remain, including data quality, algorithm transparency, and ethical concerns, which must be addressed to ensure safe and effective AI deployment. Continued research, collaboration between healthcare professionals and AI experts, and the development of robust regulatory frameworks are essential for maximizing AI’s benefits while minimizing risks. This research underscores the transformative potential of AI in healthcare and stresses the need for a multidisciplinary approach to address the ethical and regulatory complexities involved in its widespread adoption